Tumor cells (red) grown within a microstructure (host tissue; green), a so-called organoid. The Rubin Lab has been developing organoids that will serve as a tool for investigating patient-derived tumors at a cell-cell level.
Tumor cells ( red ) grown within a microstructure (host tissue; green), a so-called organoid. The Rubin Lab has been developing organoids that will serve as a tool for investigating patient-derived tumors at a cell-cell level. Alison Ferguson / BCPM - Researchers from the University of Bern and Inselspital provide an overview of the latest technologies in precision oncology. Translating these into clinical application is still a major challenge. With research projects, the Bern Center for Precision Medicine (BCPM) contributes to bringing technological progress to the patient. Tumors have significant differences depending on the person affected, even if they are the same cancer, such as breast cancer. Therefore, precision oncology targets specific genetic characteristics of a tumor and incorporates them into treatment.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
Your Benefits
- Access to all content
- Receive newsmails for news and jobs
- Post ads
